Clinical Trial Update: Intensive Adjuvant Therapy for TNBC with BRCA Gene Mutation

View source ↗

Summary

Enrollment status update for a trial of intensive adjuvant therapy in triple-negative breast cancer patients with BRCA mutations (enrolling by invitation).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Breast Carcinoma, BRCA Mutation | Status: ENROLLING_BY_INVITATION